Dr. David Iglesias, MD
Claim this profileCarilion Clinic Gynecological Oncology
Studies Ovarian Cancer
Studies Endometrial Cancer
8 reported clinical trials
20 drugs studied
Area of expertise
1Ovarian Cancer
BRCA1 positive
BRCA1
BRCA2
2Endometrial Cancer
Stage IV
Stage I
Stage III
Affiliated Hospitals
Clinical Trials David Iglesias, MD is currently running
Telemedicine Counseling
for Endometrial Cancer
To determine whether telemedicine is an acceptable addition to pre-operative counseling, compared to face-to-face communication alone for patients with endometrial cancer.
Recruiting1 award N/A
Surgical Procedures
for Reducing Ovarian Cancer Risk
This clinical trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Recruiting1 award N/A
More about David Iglesias, MD
Clinical Trial Related5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David Iglesias, MD has experience with
- Bevacizumab
- Pembrolizumab
- Carboplatin
- Paclitaxel
- Tisotumab Vedotin
- Preoperative Counseling
Breakdown of trials David Iglesias, MD has run
Ovarian Cancer
- Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)
- Chemotherapy + Immunotherapy for Recurrent Ovarian Cancer
- Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
Endometrial Cancer
Ovarian Tumors
- Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)
- Chemotherapy + Immunotherapy for Recurrent Ovarian Cancer
- Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Iglesias, MD specialize in?
David Iglesias, MD focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved BRCA1 positive patients, or patients who are BRCA1.
Is David Iglesias, MD currently recruiting for clinical trials?
Yes, David Iglesias, MD is currently recruiting for 2 clinical trials in Roanoke Virginia. If you're interested in participating, you should apply.
Are there any treatments that David Iglesias, MD has studied deeply?
Yes, David Iglesias, MD has studied treatments such as Bevacizumab, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with David Iglesias, MD?
Apply for one of the trials that David Iglesias, MD is conducting.
What is the office address of David Iglesias, MD?
The office of David Iglesias, MD is located at: Carilion Clinic Gynecological Oncology, Roanoke, Virginia 24016 United States. This is the address for their practice at the Carilion Clinic Gynecological Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.